Clinical Trials Browser

INDUSTRY × WW Domain-Containing Oxidoreductase × Thoracic × Clear all

NCT00051974 2008-02-11

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung

NCT00064636 2005-06-24

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Phase 1 Terminated

Other solid neoplasmThoracic

Advanced Non-Small Cell Lung Cancer